Emerging Opportunities in Global Markets
India has invested significant resources in erecting a biotechnology infrastructure from its biotechnology strategic plan to funding for biotechnology R&D. A panel of government, industry and think tank experts review India’s investment and its outputs to the global biotechnology endeavor. From legal infrastructure to regulations, the group will discuss what India has done right and what it needs to do to better to fully reap the fruits of its investment and to make its full contribution to global biotechnology.
Dr. Amit Kapoor was a panelist at the event titled “Emerging Opportunities in Global Markets: India’s Contribution in Global Biotech R&D”. The other panelists included-
- Prof. Stephen Sammut, Senior Fellow Health Care Management. Lecturer – Entrepreneurship atWharton School of Business
- Kate Beale, Associate Vice President, International Advocacy, Pharmaceutical Research and Manufacturers of America, PhRMA
- Dr. Christiane Hamacher,CEO, Biocon Biologics India Limited
- Amit Kapoor, Honorary Chairman, Institute for Competitiveness, India
- Dr. Cyrus Karkaria, President atLupin Limited
- Dr. Alka Sharma, Scientist G, Department of Biotechnology, Government of India
